Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

PLYX stock hub

Polaryx Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

PLYXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

173.3M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

PLYX

In the news

Latest news · PLYX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-193.7

P25 -105.6P50 -46.5P75 -3.1

ROIC-105.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All PLYX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

138

Groups with data

Currency

USD

Showing 138 of 138 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0002075320
Company name	Polaryx Therapeutics, Inc.
Country	United States
Country code	US
Cusip	73110F100
Employees	7
Enterprise value	$168.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US73110F1003
Last refreshed	2026-05-10
Market cap	$173.3M
Market cap category	Micro-Cap
Price	$3.66
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	PLYX
Website	https://polaryx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.19%
P/B ratio	37.96x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-9M
Net Income Growth Years	1%
Profit Per Employee	$-1.3M
ROA	-96.12
ROCE	-171.3
ROE	-193.7
ROIC	-105.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$5.2M
Cash	$5.1M
Current Assets	$5.2M
Current Liabilities	$605,000
Equity	$4.6M
Liabilities	$605,000
Long Term Assets	$0
Long Term Liabilities	$0
Net Cash	$5.1M
Net Cash By Market Cap	$2.97
Net Cash Growth	11.3%
Net Debt Equity	$-1.13
Tangible Book Value	$4.6M
Tangible Book Value Per Share	$0.1

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.55
Net Working Capital	$-578,000
Quick ratio	8.5
Working Capital	$4.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-32.81%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	5.32
All Time High	48.91
All Time High Change	-92.52%
All Time High Date	2026-02-02
All Time Low	2.2
All Time Low Change	66.29%
All Time Low Date	2026-02-13
ATR	0.83
Beta1y	-4.02
High	4.05
High52	48.91
High52 Date	2026-02-02
High52ch	-92.52%
Low	3.6
Low52	2.2
Low52 Date	2026-02-13
Low52ch	66.29%
Ma50ch	-31.15%
Premarket Change Percent	3.93
Premarket Price	$3.97
Premarket Volume	8,468
RSI	31.17
RSI Monthly	0
RSI Weekly	0
Sharpe ratio	-1.5x
Sortino ratio	-2.25
Total Return	-32.81%
Tr1m	-29.07%
Tr1w	-25%
Tr3m	-58.92%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.02
Operating Income	$-7.8M
Price target	$10
Price Target Change	$173

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,983,536%
Float Percent	10.53%
Shares Insiders	32.02%
Shares Institutions	3.9%
Shares Out	47,343,297
Shares Qo Q	2.36%
Shares Yo Y	32.81%
Short Float	4.77%
Short Ratio	0.43
Short Shares	0.5

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	146,897.35x
Bv Per Share	0.1
Ch1m	-29.07
Ch1w	-25
Ch3m	-58.92
Change	-4.19%
Change From Open	-5.67
Close	3.82
Days Gap	1.57
Dollar Volume	529,345.8
Earnings Date	2026-05-22
Earnings Time	bmo
EBIT	$-7.8M
EPS	$-0.2
F Score	1
Financing CF	4,466,000
Fiscal Year End	December
Founded	2,014
Is Primary Listing	1
Is Spac	No
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-24
Ma20	5.26
Ma20ch	-30.46%
Net CF	522,000
Next Earnings Date	2026-05-22
Open	3.88
Optionable	No
Position In Range	13.33
Post Close	3.66
Postmarket Change Percent	-1.37
Postmarket Price	$3.61
Pre Close	3.82
Price Date	2026-05-08
Ptbv Ratio	37.96
Relative Volume	0.98x
Share Based Comp	4,725,000
Us State	New Jersey
Volume	144,630

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does PLYX pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns PLYX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.9%

Float: +10.5% of shares outstanding

Insider ownership

+32.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

PLYX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

31.2

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-1.50

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About PLYX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current PLYX stock rating?

Polaryx Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full PLYX analysis?

The full report lives at /stocks/PLYX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for PLYX?

The latest report frames PLYX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the PLYX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.